| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/26/1993 | CN1020857C Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses |
| 05/26/1993 | CA2083553A1 Immunogen composition |
| 05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
| 05/25/1993 | US5213795 Encephalomyocarditis virus vaccine |
| 05/25/1993 | CA1318457C Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/1993 | EP0542466A2 Baculovirus transfer vectors |
| 05/19/1993 | EP0542309A1 Hair care product |
| 05/19/1993 | EP0542303A2 Process for preparing a biologically active bloodserum |
| 05/19/1993 | EP0542145A1 Oligosaccharides with antigenic determinants from the jelly coat of amphibian eggs |
| 05/19/1993 | EP0541721A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 05/19/1993 | EP0541692A1 Herpes simplex virus vp16 vaccines |
| 05/19/1993 | EP0541691A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 05/19/1993 | EP0541663A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 05/19/1993 | EP0541629A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 05/19/1993 | EP0343186B1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY $i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM |
| 05/19/1993 | CN1020752C Vaccines and immunoassays for acquired immune deficiency syndrome |
| 05/19/1993 | CN1020733C Process for preparing covalent conjunct agent of bacterial polysaccharide and immunogen protein |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212156 Srif-related peptides and uses thereof |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5212072 Genetic engineering and DNA sequences |
| 05/18/1993 | US5211938 Method of detection of malignant and non-malignant lesions by photochemotherapy of protoporphyrin IX percursors |
| 05/18/1993 | CA1317899C Stabilization of antibodies |
| 05/18/1993 | CA1317880C Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
| 05/13/1993 | WO1993009238A1 Feline leukemia virus vaccines |
| 05/13/1993 | WO1993009236A1 Myogenic vector systems |
| 05/13/1993 | WO1993009230A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 05/13/1993 | WO1993009228A1 TGF-β TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 05/13/1993 | WO1993009221A1 Targeted delivery of virus vector to mammalian cells |
| 05/13/1993 | WO1993009141A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | WO1993009139A1 Production of complementary dna representing hepatitis a viral sequences by recombinant dna methods and uses therefor |
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993008838A1 Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate |
| 05/13/1993 | WO1993008837A1 Stabilised antibodies |
| 05/13/1993 | WO1993008836A1 Induction of protection against viral infection by synergy between viral proteins and viral peptides |
| 05/13/1993 | WO1993008834A1 Vaccine against pathogens of mucosae using liposomes |
| 05/13/1993 | WO1993008817A1 Cd8 binding domain peptides |
| 05/13/1993 | WO1993008799A1 Endothelin receptor antagonists |
| 05/13/1993 | DE4136553A1 Impfstoff gegen schleimhauterreger und herstellungsverfahren Vaccine against pathogen mucosa and manufacturing processes |
| 05/13/1993 | CA2122820A1 Endothelin receptor antagonists |
| 05/13/1993 | CA2122617A1 Myogenic vector systems |
| 05/13/1993 | CA2122491A1 Tgf-.beta. type receptor cdnas and uses therefor |
| 05/13/1993 | CA2122374A1 Oral pharmaceutical composition containing polyethylene glycol immunoglobulin conjugate for reconstitution of secretory immunity and method of reconstituting secretory immunity |
| 05/13/1993 | CA2122359A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | CA2122266A1 Cd8 binding domain peptides |
| 05/13/1993 | CA2122263A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
| 05/12/1993 | EP0541418A1 Preparation of antigens and vaccines of the mystery disease virus, obtained antigens and vaccines for the prevention of this disease |
| 05/12/1993 | EP0541335A1 Recombinant DNA sequences and plasmids for cellular immunity vaccines from bacterial toxinantigen conjugates |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 05/12/1993 | EP0541089A2 cDNA of human hepatitis C virus, its clone and use thereof |
| 05/12/1993 | EP0540859A1 Anthracycline prodrugs |
| 05/12/1993 | EP0540675A1 Inhibition of mac-1 receptor binding to fibrinogen using d 30? homologs |
| 05/12/1993 | EP0540645A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 05/12/1993 | EP0540612A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 05/12/1993 | EP0540599A1 Adoptive immunotherapy with interleukin-7 |
| 05/12/1993 | EP0540586A1 Binding domains |
| 05/12/1993 | EP0540525A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 05/12/1993 | EP0160670B1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 05/12/1993 | CA2082577A1 Expression system |
| 05/11/1993 | US5210180 Nonapeptides |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5210072 Immunomodulant, suppressing IgE formation |
| 05/11/1993 | US5210035 Non-reventing live vaccines |
| 05/11/1993 | US5209929 Immunization against Babesiosis using purified merozoite surface antigens of Basesia bigemina |
| 05/11/1993 | CA1317557C Breast tumor-associated antigen and monoclonal antibodies specific thereto |
| 05/11/1993 | CA1317544C Method for labeling antibodies with a metal ion |
| 05/09/1993 | CA2081952A1 Recombinant dna sequences and plasmids for cellular immunity vaccines from bacterial toxin-antigen conjugates, and methods of their use |
| 05/05/1993 | EP0540457A1 Improvements in Borrelia burgdorferi diagnosis and prophylaxis |
| 05/05/1993 | EP0540135A2 Attenuated measles vaccine virus strain containing specific nucleotide sequence and a method for its absolute identification |
| 05/05/1993 | EP0540128A1 Nematode vaccine |
| 05/05/1993 | EP0540063A1 Hyperimmune serum for endotoxin associated disease, detoxified endotoxin and bacterial mutant |
| 05/05/1993 | EP0539751A1 Biodegradable polymer composition |
| 05/05/1993 | EP0539748A1 Polypeptides capable of binding to heavy chains of IL-2 receptors |
| 05/05/1993 | EP0539547A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom |
| 05/05/1993 | EP0539522A1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 05/05/1993 | EP0539516A1 Asphodelus composition for increasing white blood cell count |
| 05/05/1993 | EP0539492A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 05/05/1993 | EP0539457A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
| 05/05/1993 | EP0539455A1 Multivalent anti-cytokine immunoglobulins |
| 05/05/1993 | EP0539395A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
| 05/05/1993 | CN1020472C Mammalian interleukin-4 |
| 05/05/1993 | CN1020407C Process for preparation of influenze vaccine |
| 05/04/1993 | US5208321 Labeled antigens |
| 05/04/1993 | US5208218 T cell growth factor glycoproteins |
| 05/04/1993 | US5208146 Murine monoclonal anti-idiotype antibodies |
| 05/04/1993 | US5208144 Genetic engineering and hybridization |
| 05/04/1993 | US5208024 Vaccine against E. coli septicaemia in poultry |
| 05/04/1993 | US5208023 Vaccine against avian encephalomyelitis |
| 05/04/1993 | US5208022 Non-malignant cells coupled to adjuvants and their use in a method to induce anti-tumor immunity |
| 05/04/1993 | CA1317288C Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 05/02/1993 | CA2081950A1 Vaccine for the prevention of infections caused by pasteurella haemolytica |
| 04/30/1993 | CA2081638A1 Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease |
| 04/29/1993 | WO1993008306A1 Improvement in borrelia burgdorferi diagnosis and prophylaxis |
| 04/29/1993 | WO1993008301A1 Improved method |
| 04/29/1993 | WO1993008299A1 Preparation of recombinant borrelia proteins |
| 04/29/1993 | WO1993008290A1 Enhanced immunogenicity using leukotoxin chimeras |
| 04/29/1993 | WO1993008286A1 VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI (Bb) |
| 04/29/1993 | WO1993008284A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression |
| 04/29/1993 | WO1993008283A1 Vaccines for actinobacillus pleuropneumoniae |
| 04/29/1993 | WO1993008280A1 Recombitope peptides |